Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 17, 2013 14:45 ET | Source: Bavarian Nordic A/S

Bavarian Nordic A/S - Report on the Results of the Annual General Meeting, held 17 April 2013

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} KVISTGAARD, Denmark, April 17, 2013 - Bavarian Nordic...
April 17, 2013 14:45 ET | Source: Bavarian Nordic A/S

Bavarian Nordic A/S - Orientering om forløb af ordinær generalforsamling den 17. april 2013

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} KVISTGÅRD, Danmark - 17. april 2013 - Bavarian Nordic...
April 16, 2013 11:00 ET | Source: Bavarian Nordic A/S

Bavarian Nordic Receives Contract Valued up to USD 228 Million from the U.S. Government Securing Continued Production and Deliveries of IMVAMUNE® Smallpox Vaccine

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} New order replenishes existing doses in U.S....
April 16, 2013 11:00 ET | Source: Bavarian Nordic A/S

Bavarian Nordic indgår ny kontrakt på op til DKK 1,3 mia. med den amerikanske regering om fortsat levering af IMVAMUNE® koppevaccine

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Ordren fornyr det eksisterende beredskabslager og...
April 08, 2013 01:00 ET | Source: Bavarian Nordic A/S

Bavarian Nordic Agrees on Interim Analysis with the FDA and Provides an Update on its PROSPECT Phase 3 Trial

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} KVISTGAARD, Denmark, April 8, 2013 - Bavarian Nordic...
April 08, 2013 01:00 ET | Source: Bavarian Nordic A/S

Bavarian Nordic modtager tilladelse fra de amerikanske sundhedsmyndigheder (FDA) til at gennemføre interim analyse og opdaterer på PROSPECT fase 3 forsøget

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} KVISTGÅRD, Danmark - 8. april 2013 - Bavarian Nordic...
March 19, 2013 03:00 ET | Source: Bavarian Nordic A/S

Bavarian Nordic A/S - Notice Convening Ordinary General Meeting

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Pursuant to Article 10 of the Articles of Association,...
March 19, 2013 03:00 ET | Source: Bavarian Nordic A/S

Bavarian Nordic A/S - Indkaldelse til ordinær generalforsamling

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} I overensstemmelse med vedtægternes § 10 indkaldes...
March 13, 2013 06:09 ET | Source: Bavarian Nordic A/S

Bavarian Nordic A/S - Articles of Association

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Bavarian Nordic A/S - Articles of Association ...
March 13, 2013 06:09 ET | Source: Bavarian Nordic A/S

Bavarian Nordic A/S - Vedtægter

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Vedtægter for Bavarian Nordic A/S ...